Reports demonstrate that COL6A3 mutations cause a wide range of disorders characterized by muscle weakness and connective tissue abnormalities, ranging from severe Ullrich congenital muscular dystrophy to mild Bethlem myopathy46–48. This evidence concerns the gene COL6A3 and Ullrich congenital muscular dystrophy.